Allt inom
New animal study shows additional benefits with PharmaShell®
Uppsala 6th November 2017
New animal study shows additional benefits with PharmaShell®
In Nanexa’s ongoing animal study, the first results have shown that the further development of the PharmaShell® technology significantly reduces the initial concentration peak.
Nanexa expands its business opportunities with self-owned project
Uppsala 27th Oct 2017
Nanexa expands its business opportunities with self-owned product project in the field of oncology.
The decision on last monday’s meeting of shareholders to proceed with the new share issue proposed by the Board creates the financial opportunities for the company to start and run a product project on its own.